Sagimet Biosciences Inc. (SGMT) ROA
- 2026-06-30: ROA -17.87%.
- 2026-03-31: ROA -40.38%.
- 2025-12-31: ROA -43.82%.
- 2025-09-30: ROA -44.91%.
Complete source-backed roa history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -17.87% |
| 2026-03-31 | -40.38% |
| 2025-12-31 | -43.82% |
| 2025-09-30 | -44.91% |
| 2025-06-30 | -43.22% |
| 2025-03-31 | -39.07% |
| 2024-12-31 | -28.43% |
| 2024-09-30 | -21.47% |
| 2024-06-30 | -15.48% |
| 2024-03-31 | -14.35% |
| 2023-12-31 | -28.82% |
| 2023-09-30 | -26.15% |
| 2023-06-30 | -130.40% |
| 2022-12-31 | -92.33% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -43.82% |
| 2024-12-31 | -28.43% |
| 2023-12-31 | -28.82% |
| 2022-12-31 | -92.33% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |